![Thomas Langenickel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Langenickel
Direttore Tecnico/Scientifico/R&S presso
GUBRA A/S
Profilo
Thomas Langenickel is Chief Medical & Development Officer at Gubra A since 2026.
Formerly, Dr. Langenickel was Chief Medical Officer at ETHRIS GmbH.
Dr. Langenickel earned a doctorate from Humboldt-Universität zu Berlin.
Posizioni attive di Thomas Langenickel
| Società | Posizione | Inizio |
|---|---|---|
| GUBRA A/S | Direttore Tecnico/Scientifico/R&S | 05/01/2026 |
Precedenti posizioni note di Thomas Langenickel
| Società | Posizione | Fine |
|---|---|---|
ETHRIS GmbH
 ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thomas Langenickel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gubra A/S
 Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
ETHRIS GmbH
ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Health Technology |
